Ramius Advisors’s Opiant Pharmaceuticals OPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-55,298
Closed -$1.12M – 162
2022
Q4
$1.12M Buy
+55,298
New +$848K 1.07% 15

Ramius Advisors's OPNT Position: Q1 2023 in Review

Ramius Advisors sold out of Opiant Pharmaceuticals (OPNT) in Q1 2023, closing a stake of 55,298 shares — an estimated $1.12M sold.

Ramius Advisors first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $1.12M in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

  • Ramius Advisors reported no remaining Opiant Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Ramius Advisors sold 55,298 Opiant Pharmaceuticals shares in Q1 2023, an estimated $1.12M.
  • Ramius Advisors first reported a position in Opiant Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Ramius Advisors's Opiant Pharmaceuticals position peaked at $1.12M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals as of Q1 2023.

Based on Ramius Advisors's 13F filing for Q1 2023, filed 11 May 2023.